Eurazeo completed the acquisition of Cranial Technologies from BPOC.

Eurazeo, a global investment company, completed the acquisition of Cranial Technologies, a treatment provider and manufacturer of helmets used for treating infants with various forms of plagiocephaly, brachycephaly and scaphocephaly, from BPOC, one of the longest-tenured healthcare private equity firms. Financial terms were not disclosed. "Over the last several years, BPOC has been an invaluable partner to us as we executed on our significant growth plans for the company. We sincerely appreciate all of BPOC's support, resources, and guidance," Debbie James, Cranial Technologies CEO.